Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

It's not just talk. Americans' spending on GLP-1 drugs including Ozempic and Wegovy has skyrocketed in the last five years.

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

Employers face rising GLP-1 demand. Here are tips to manage costs while maintaining care access.

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes were for GLP-1 receptor agonists, such as semaglutide or tirzepatide. New ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...

The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...